ArticleMolecular pharmaceutics2025

Pilot Study of Intratumoral Immunotherapy with Cowpea Mosaic Virus Nanoparticles: Safety in Refractory Canine Oral Tumors.

Pablo Delgado-Bonet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.